Alnylam Pharmaceuticals
ALNY
#561
Rank
ยฃ33.07 B
Marketcap
ยฃ249.38
Share price
-0.94%
Change (1 day)
25.03%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company